학술논문

Carbon monoxide and prognosis in smokers hospitalised with acute cardiac events: a multicentre, prospective cohort studyResearch in context
Document Type
article
Author
Jean-Guillaume DillingerThéo PezelClément DelmasGuillaume SchurtzAntonin TrimailleNicolas PilieroClaire BouletiBenoit LattucaStéphane AndrieuJulien FabreReza Rossanaly VasramJean-Claude DibVictor AboyansCharles FauvelFrancois RoubilleEdouard GerbaudAlbert BoccaraEtienne PuymiratSolenn ToupinEric VicautPatrick HenryEmeric AlbertFranck AlbertSean AlvainNabil AmriSabir AttouSimon AuvraySonia AzzakaniRuben AzencotMarc BedossaFranck BoccaraThomas BochatonEric Bonnefoy-CudrazGuillaume BonnetNabil BoualiOcéane BouchotTanissia BoukertoutaJean-Baptiste BretteMarjorie CanuAures ChaibClement CharbonnelAnne-Solene ChaussadeAlexandre CoppensYves CottinArthur DarmonElena de AngelisLaura DelsarteAntoine DeneyClemence DocqValentin DupasquierMeyer ElbazAntony El HadadAmine El OuahidiNacim EzzouhairiDamien FardÉdouard GerbaudMartine GilardMarc GoralskiNissim GrinbergAlain GrentzingerMarie Hauguel-MoreauFabien HuetThomas LandemaineLéo LemarchandThomas LevasseurPascal LimLaura Maitre BallesterosNicolas MansencalBenjamin MarieDavid MartinezBenoit MeratChristophe MeuneDamien MillischerThomas MoinePascal NhanNathalie NoirclercPatrick OhlmannFabien PicardThibaut PommierArthur RamonatxoFrançois RoubilleVincent RouleMathilde StevenardDavid SulmanFédérico SwedskyVictoria TeaEugénie ThevenetChristophe ThuaireChristophe TronGuillaume ViboudDominique YomiCyril Zakine
Source
EClinicalMedicine, Vol 67, Iss , Pp 102401- (2024)
Subject
Carbon monoxide
Smoking
Tobacco
Acute cardiac events
Death
Cardiovascular events
Medicine (General)
R5-920
Language
English
ISSN
2589-5370
Abstract
Summary: Background: Smoking cigarettes produces carbon monoxide (CO), which can reduce the oxygen-carrying capacity of the blood. We aimed to determine whether elevated expiratory CO levels would be associated with a worse prognosis in smokers presenting with acute cardiac events. Methods: From 7 to 22 April 2021, expiratory CO levels were measured in a prospective registry including all consecutive patients admitted for acute cardiac event in 39 centres throughout France. The primary outcome was 1-year all-cause death. Initial in-hospital major adverse cardiac events (MAE; death, resuscitated cardiac arrest and cardiogenic shock) were also analysed. The study was registered at ClinicalTrials.gov (NCT05063097). Findings: Among 1379 patients (63 ± 15 years, 70% men), 368 (27%) were active smokers. Expiratory CO levels were significantly raised in active smokers compared to non-smokers. A CO level >11 parts per million (ppm) found in 94 (25.5%) smokers was associated with a significant increase in death (14.9% for CO > 11 ppm vs. 2.9% for CO ≤ 11 ppm; p 11 ppm was associated with a significant increase in MAE in smokers during initial hospitalisation after adjustment for comorbidities (odds ratio [OR] 15.75, 95% CI [5.56–44.60]) or parameters of in-hospital severity (OR 10.67, 95% CI [4.06–28.04]). In the overall population, CO > 11 ppm but not smoking was associated with an increased rate of all-cause death (HR 4.03, 95% CI [2.33–6.98] and 1.66 [0.96–2.85] respectively). Interpretation: Elevated CO level is independently associated with a 6-fold increase in 1-year death and 10-fold in-hospital MAE in smokers hospitalized for acute cardiac events. Funding: Grant from Fondation Coeur & Recherche.